Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mortimer Poncz

Showing results (151-160 of 165) with videos related to

Pageof 17
Sort By:
Blood Advances|March 14, 2025
Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopeniaAlexander Dupuy, Xiaoming Liu, Yvonne Kong, et al.
The Journal of Clinical Investigation|May 12, 2015
Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cellsJi-Yoon Noh, Shilpa Gandre-Babbe, Yuhuan Wang, et al.
Blood|December 17, 2013
High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombastheniaSpencer K Sullivan, Jason A Mills, Sevasti B Koukouritaki, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood|June 30, 2026
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood Advances|January 4, 2018
Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopeniaDouglas B Cines, Serge V Yarovoi, Sergei V Zaitsev, et al.
Blood|September 2, 2018
<i>GNE</i> variants causing autosomal recessive macrothrombocytopenia without associated muscle wastingShoshana Revel-Vilk, Ela Shai, Ernest Turro, et al.
Blood|January 20, 2026
Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic riskYanki Yarman, Xuefei Zhao, Hyunsook Ahn, et al.
Cell Host & Microbe|December 19, 2012
Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarialsMelissa S Love, Melanie G Millholland, Satish Mishra, et al.
The Journal of Clinical Investigation|March 10, 2026
Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipientsLiang Zhao, Sokratis A Apostolidis, Aae Suzuki, et al.
Pageof 17

Showing results (151-160 of 165) with videos related to

Sort By:
Pageof 17
Blood Advances|March 14, 2025
Endothelial cell activation enhances thromboinflammation in vaccine-induced immune thrombotic thrombocytopeniaAlexander Dupuy, Xiaoming Liu, Yvonne Kong, et al.
The Journal of Clinical Investigation|May 12, 2015
Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cellsJi-Yoon Noh, Shilpa Gandre-Babbe, Yuhuan Wang, et al.
Blood|December 17, 2013
High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombastheniaSpencer K Sullivan, Jason A Mills, Sevasti B Koukouritaki, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood|June 30, 2026
Antiphospholipid syndrome (APS) is a platelet factor 4 (PF4)-centric immunothrombotic disorderConroy O Field, Amrita Sarkar, Khalil Bdeir, et al.
Blood Advances|January 4, 2018
Polyphosphate/platelet factor 4 complexes can mediate heparin-independent platelet activation in heparin-induced thrombocytopeniaDouglas B Cines, Serge V Yarovoi, Sergei V Zaitsev, et al.
Blood|September 2, 2018
<i>GNE</i> variants causing autosomal recessive macrothrombocytopenia without associated muscle wastingShoshana Revel-Vilk, Ela Shai, Ernest Turro, et al.
Blood|January 20, 2026
Understanding how a highly prevalent GRK5 polymorphism affects platelets and enhances thrombotic riskYanki Yarman, Xuefei Zhao, Hyunsook Ahn, et al.
Cell Host & Microbe|December 19, 2012
Platelet factor 4 activity against P. falciparum and its translation to nonpeptidic mimics as antimalarialsMelissa S Love, Melanie G Millholland, Satish Mishra, et al.
The Journal of Clinical Investigation|March 10, 2026
Graft-derived VWF drives platelet activation and thrombocytopenia during porcine liver xenotransplantation to brain-dead human recipientsLiang Zhao, Sokratis A Apostolidis, Aae Suzuki, et al.
Pageof 17